<unk>  is a methylxanthine and blood modifier agent that is FDA approved for the treatment of treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs.   Common adverse reactions include nausea , vomiting.
Pentoxifylline
Iotalamic acid
Apixaban
Abciximab
Enoxaparin
Cilostazol
Picloxydine
Dabigatran